Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

VENLAFAXINE HYDROCHLORIDE

VENLAFAXINE HYDROCHLORIDE

Standard Dose
EQ 225MG BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview VENLAFAXINE HYDROCHLORIDE is listed in Drugs@FDA under application 218180 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient VENLAFAXINE HYDROCHLORIDE Form and strength TABLET, EXTENDED RELEASE;ORAL - EQ 225MG BASE Sponsor TORRENT Submission history Latest submission status date: 2025-01-28 00:00:00.

Structured Monograph

Clinical summary

Approval overview VENLAFAXINE HYDROCHLORIDE is listed in Drugs@FDA under application 218180 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient VENLAFAXINE HYDROCHLORIDE Form and strength TABLET, EXTENDED RELEASE;ORAL - EQ 225MG BASE Sponsor TORRENT Submission history Latest submission status date: 2025-01-28 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.